ZEMURON Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Zemuron, and what generic alternatives are available?

Zemuron is a drug marketed by Organon Usa Inc and is included in one NDA.

The generic ingredient in ZEMURON is rocuronium bromide. There are eleven drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the rocuronium bromide profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Zemuron

A generic version of ZEMURON was approved as rocuronium bromide by HOSPIRA on November 26^th, 2008.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for ZEMURON?
What are the global sales for ZEMURON?
What is Average Wholesale Price for ZEMURON?

Summary for ZEMURON

US Patents:	0
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	75
Clinical Trials:	17
Patent Applications:	1,278
DailyMed Link:	ZEMURON at DailyMed

Drug patent expirations by year for ZEMURON

Recent Clinical Trials for ZEMURON

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
University of Rijeka	N/A
McGill University Health Centre/Research Institute of the McGill University Health Centre	N/A
McGill University Health Center	N/A

See all ZEMURON clinical trials

US Patents and Regulatory Information for ZEMURON

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Organon Usa Inc	ZEMURON	rocuronium bromide	INJECTABLE;INJECTION	020214-001	Mar 17, 1994		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Organon Usa Inc	ZEMURON	rocuronium bromide	INJECTABLE;INJECTION	020214-002	Mar 17, 1994		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Organon Usa Inc	ZEMURON	rocuronium bromide	INJECTABLE;INJECTION	020214-003	Mar 17, 1994		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for ZEMURON

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Organon Usa Inc	ZEMURON	rocuronium bromide	INJECTABLE;INJECTION	020214-001	Mar 17, 1994	⤷ Sign Up	⤷ Sign Up
Organon Usa Inc	ZEMURON	rocuronium bromide	INJECTABLE;INJECTION	020214-003	Mar 17, 1994	⤷ Sign Up	⤷ Sign Up
Organon Usa Inc	ZEMURON	rocuronium bromide	INJECTABLE;INJECTION	020214-002	Mar 17, 1994	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for ZEMURON

See the table below for patents covering ZEMURON around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
European Patent Office	0287150	NOVEL 2 BETA-MORPHOLINO-ANDROSTANE DERIVATIVES AND PROCESSES FOR THEIR PREPARATION	⤷ Sign Up
New Zealand	224228	16-SUBSTITUTED 2B-MORPHOLINO-ANDROSTANE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS	⤷ Sign Up
Netherlands	940010		⤷ Sign Up
United Kingdom	8708886		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

Supplementary Protection Certificates for ZEMURON

Subscribe to access the full database, or Sign Up
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0287150	96C0038	Belgium	⤷ Sign Up	PRODUCT NAME: ROCURONIUMBROMIDE; NAT. REGISTRATION NO/DATE: 63 IS 9 F 12 19960709; FIRST REGISTRATION: NL RVG 16946 19940406
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

AI Research Assistant

Questions you can ask:

Summary for ZEMURON

Recent Clinical Trials for ZEMURON

Make Better Decisions: Try a trial or see plans & pricing